Investigational therapies targeting quorum-sensing for the treatment of Staphylococcus aureus infections.
about
Investigational drugs to treat methicillin-resistant Staphylococcus aureusQuorum-sensing regulation in staphylococci-an overviewStructure-Function Analyses of a Staphylococcus epidermidis Autoinducing Peptide Reveals Motifs Critical for AgrC-type Receptor ModulationRole of Phenol-Soluble Modulins in Formation of Staphylococcus aureus Biofilms in Synovial Fluid.Nanoporous Superhydrophobic Coatings that Promote the Extended Release of Water-Labile Quorum Sensing Inhibitors and Enable Long-Term Modulation of Quorum Sensing in Staphylococcus aureus.Toxin Mediates Sepsis Caused by Methicillin-Resistant Staphylococcus epidermidis.Characterization of structural elements in native autoinducing peptides and non-native analogues that permit the differential modulation of AgrC-type quorum sensing receptors in Staphylococcus aureus.Virulence determinants associated with the Asian community-associated methicillin-resistant Staphylococcus aureus lineage ST59.Highly Stable, Amide-Bridged Autoinducing Peptide Analogues that Strongly Inhibit the AgrC Quorum Sensing Receptor in Staphylococcus aureus.Prevention and treatment of Staphylococcus aureus biofilms.Staphylococcus aureus pathogenesis in diverse host environments.Antisense locked nucleic acids targeting agrA inhibit quorum sensing and pathogenesis of community-associated methicillin-resistant Staphylococcus aureus.Tuning of the Lethal Response to Multiple Stressors with a Single-Site Mutation during Clinical Infection by Staphylococcus aureus.The Agr Quorum Sensing System Represses Persister Formation through Regulation of Phenol Soluble Modulins in Staphylococcus aureus.Targeting Virulence in Staphylococcus aureus by Chemical Inhibition of the Accessory Gene Regulator System In Vivo.Pathogen elimination by probiotic Bacillus via signalling interference
P2860
Q26780246-B8B44FAF-F2EC-434D-A9A7-80D0AB632C07Q26823976-E54B6900-772F-452E-A87B-AA8AF2199EEDQ28830075-EB971B1D-F59C-48B7-918A-E5E95D96E1C7Q35745525-994880D5-77FD-4CBE-B8E9-4FB199B16866Q36158783-3006624A-C992-4BAA-806B-4CDBFEC674FDQ36267565-30D6CB4D-D9EF-4216-BF68-AE0ADE076F62Q36378301-9303F223-3850-43FD-B59F-4E89DB7191ECQ37000378-5FE6C34D-5D36-430B-9216-5B3AC2B39E8AQ37149488-3A8132DC-7D6B-4936-9159-9ECAE16F2686Q37482155-E0F3A117-0A44-4E26-91A7-E70A435AF763Q40365019-A9470573-3925-4C0C-836F-11B8FA16B080Q40513076-1CCFF0A1-CF5C-40B4-9B48-DAD0ED93BCBFQ42638883-7AB0D898-8C88-4D82-82E2-7D2DEBAC5EF1Q47156077-F9DDC5B6-A39A-412B-9DB6-335D0E07E61FQ48188872-7A53A424-055B-48B0-B334-CC72E443DC7EQ57285563-AD1F882E-8CCD-441D-924F-0040476A3563
P2860
Investigational therapies targeting quorum-sensing for the treatment of Staphylococcus aureus infections.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Investigational therapies targ ...... phylococcus aureus infections.
@en
type
label
Investigational therapies targ ...... phylococcus aureus infections.
@en
prefLabel
Investigational therapies targ ...... phylococcus aureus infections.
@en
P2860
P1476
Investigational therapies targ ...... aphylococcus aureus infections
@en
P2093
Anthony J Yeh
Gordon Y C Cheung
P2860
P304
P356
10.1517/13543784.2015.1019062
P407
P577
2015-02-23T00:00:00Z